The observed lipid improvements in clinical trials occurred in the context of diabetes treatment, and the magnitude of cholesterol reduction is substantially less than that achieved with established lipid-lowering therapies such as statins
Concerning the critical nuances of utilizing topiramate and managing any unintended effects during psychiatric illness treatment, those affected should consult healthcare professionals they trust who are knowledgeable in symptom management appropriate for their situational needs
et al., 2024), each coinciding with anxiety- and depression-like behaviors
With seven additional Phase III readouts expected in 2026, we believe retatrutide could become an important option for patients with significant weight loss needs and certain complications, including knee osteoarthritis." What were the results from the TRIUMPH-4 Phase III trial
Six weeks of GLP-1 infusion resulted in significant improvements in fasting (decrease of 4.3 mM glucose) and 8 h mean glucose (decrease of 5.5 mM), fasting and mean 8h free fatty acids, a reduction in HbA1c from 9.2% to 7.9%, a decrease in fructosamine from 349 uM to 282 uM, and a reduction in gastric emptying 3,4